Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

HTBX

Heat Biologics (HTBX)

Heat Biologics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:HTBX
日付受信時刻ニュースソース見出しコード企業名
2023/05/1605 : 34Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
2023/05/1605 : 28Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2023/04/0105 : 15Edgar (US Regulatory)Annual Report (10-k)AMEX:HTBXHeat Biologics Inc
2023/04/0105 : 09Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2023/03/2405 : 06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2023/03/1320 : 54Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2023/02/0306 : 06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2022/12/3106 : 06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:HTBXHeat Biologics Inc
2022/12/1007 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
2022/12/1007 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
2022/12/1006 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
2022/11/1506 : 54Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
2022/11/1506 : 46Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2022/09/1705 : 36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2022/08/2220 : 31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2022/08/1105 : 12Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
2022/08/1105 : 07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2022/06/0705 : 29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:HTBXHeat Biologics Inc
2022/05/1706 : 25Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
2022/05/1705 : 44GlobeNewswire Inc.NightHawk Biosciences Provides First Quarter 2022 Business UpdateAMEX:HTBXHeat Biologics Inc
2022/05/1021 : 00GlobeNewswire Inc.NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35AMEX:HTBXHeat Biologics Inc
2022/05/0320 : 15Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2022/05/0320 : 00GlobeNewswire Inc.Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open TodayAMEX:HTBXHeat Biologics Inc
2022/04/2721 : 00GlobeNewswire Inc.Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian GovernmentAMEX:HTBXHeat Biologics Inc
2022/04/2021 : 08Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
2022/04/2021 : 00GlobeNewswire Inc.Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys TherapeuticsAMEX:HTBXHeat Biologics Inc
2022/04/2000 : 00GlobeNewswire Inc.Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company’s Evolution, Therapeutic Pipeline Expansion, Vertical Integration and New Biodefense CapabilitiesAMEX:HTBXHeat Biologics Inc
2022/04/1905 : 00GlobeNewswire Inc.REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
2022/04/1821 : 30GlobeNewswire Inc.Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing FacilityAMEX:HTBXHeat Biologics Inc
2022/04/1501 : 35GlobeNewswire Inc.Heat Biologics’ Announces Planned Investor and Media Livestream Event to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
 Showing the most relevant articles for your search:AMEX:HTBX